SPY328.57+2.05 0.63%
DIA266.04+1.69 0.64%
IXIC10,875.20+129.93 1.21%

RBC Capital Maintains Sector Perform on Amneal Pharmaceuticals, Raises Price Target to $4

RBC Capital analyst Randall Stanicky maintains Amneal Pharmaceuticals (NYSE:AMRX) with a Sector Perform and raises the price target from $3 to $4.

Benzinga · -

RBC Capital analyst Randall Stanicky maintains Amneal Pharmaceuticals (NYSE:AMRX) with a Sector Perform and raises the price target from $3 to $4.